Does the media favor PROF or NNOX?

In the previous week, Nano-X Imaging had 11 more articles in the media than Profound Medical. MarketBeat recorded 15 mentions for Nano-X Imaging and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.93 beat Nano-X Imaging's score of 0.18 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 2 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Is ELMD or NNOX more profitable?

Electromed has a net margin of 11.34% compared to Nano-X Imaging's net margin of -926.05%. Electromed's return on equity of 15.71% beat Nano-X Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Electromed 11.34% 15.71% 13.37% Nano-X Imaging -926.05% -116.93% -100.67%

Does the media favor ELMD or NNOX?

In the previous week, Nano-X Imaging had 13 more articles in the media than Electromed. MarketBeat recorded 15 mentions for Nano-X Imaging and 2 mentions for Electromed. Electromed's average media sentiment score of 0.90 beat Nano-X Imaging's score of 0.18 indicating that Electromed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Electromed 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 2 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Is STIM or NNOX more profitable?

Neuronetics has a net margin of -19.62% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Neuronetics -19.62% -125.11% -22.15% Nano-X Imaging -926.05% -116.93% -100.67%

Does the media favor STIM or NNOX?

In the previous week, Nano-X Imaging had 4 more articles in the media than Neuronetics. MarketBeat recorded 15 mentions for Nano-X Imaging and 11 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.66 beat Nano-X Imaging's score of 0.18 indicating that Neuronetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 2 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, NNOX or PDEX?

Pro-Dex has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nano-X Imaging $15.63M 3.64 -$75.02M -$2.14 N/A Pro-Dex $77.55M 2.59 $13.66M $4.13 15.21

Is NNOX or PDEX more profitable?

Pro-Dex has a net margin of 17.62% compared to Nano-X Imaging's net margin of -926.05%. Pro-Dex's return on equity of 25.13% beat Nano-X Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Nano-X Imaging -926.05% -116.93% -100.67% Pro-Dex 17.62% 25.13% 16.02%

Does the media refer more to NNOX or PDEX?

In the previous week, Nano-X Imaging had 7 more articles in the media than Pro-Dex. MarketBeat recorded 15 mentions for Nano-X Imaging and 8 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.60 beat Nano-X Imaging's score of 0.18 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 2 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Pro-Dex 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Nano-X Imaging (NNOX) Competitors

$0.72 -0.01 (-0.86%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$0.73 +0.01 (+0.72%)

As of 09/11/2026 07:30 PM Eastern

Compare

NNOX vs. PROF, ELMD, STIM, PDEX, and CNXU

Should you buy Nano-X Imaging stock or one of its competitors? Nano-X Imaging's main competitors and comparable companies include Profound Medical (PROF), Electromed (ELMD), Neuronetics (STIM), Pro-Dex (PDEX), and Conexeu Sciences (CNXU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Nano-X Imaging compare to Profound Medical?

Profound Medical (NASDAQ:PROF) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Nano-X Imaging had 11 more articles in the media than Profound Medical. MarketBeat recorded 15 mentions for Nano-X Imaging and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.93 beat Nano-X Imaging's score of 0.18 indicating that Profound Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nano-X Imaging	2 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Profound Medical has higher revenue and earnings than Nano-X Imaging. Profound Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$19.09M	11.43	-$42.57M	-$0.98	N/A
Nano-X Imaging	$15.63M	3.64	-$75.02M	-$2.14	N/A

Profound Medical presently has a consensus target price of $11.50, indicating a potential upside of 92.63%. Nano-X Imaging has a consensus target price of $4.33, indicating a potential upside of 498.69%. Given Nano-X Imaging's higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Profound Medical has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Profound Medical has a net margin of -171.57% compared to Nano-X Imaging's net margin of -926.05%. Profound Medical's return on equity of -63.03% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-171.57%	-63.03%	-51.24%
Nano-X Imaging	-926.05%	-116.93%	-100.67%

Summary

Profound Medical beats Nano-X Imaging on 10 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to Electromed?

Electromed (NYSE:ELMD) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

Electromed currently has a consensus price target of $43.75, indicating a potential upside of 60.55%. Nano-X Imaging has a consensus price target of $4.33, indicating a potential upside of 498.69%. Given Nano-X Imaging's higher possible upside, analysts plainly believe Nano-X Imaging is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Electromed has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Electromed has a net margin of 11.34% compared to Nano-X Imaging's net margin of -926.05%. Electromed's return on equity of 15.71% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Nano-X Imaging	-926.05%	-116.93%	-100.67%

In the previous week, Nano-X Imaging had 13 more articles in the media than Electromed. MarketBeat recorded 15 mentions for Nano-X Imaging and 2 mentions for Electromed. Electromed's average media sentiment score of 0.90 beat Nano-X Imaging's score of 0.18 indicating that Electromed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nano-X Imaging	2 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Electromed has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$73.78M	3.09	$5.15M	$1.31	20.80
Nano-X Imaging	$15.63M	3.64	-$75.02M	-$2.14	N/A

40.8% of Electromed shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 10.5% of Electromed shares are owned by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Electromed beats Nano-X Imaging on 12 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

53.6% of Neuronetics shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 8.4% of Neuronetics shares are held by insiders. Comparatively, 7.7% of Nano-X Imaging shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Neuronetics has higher revenue and earnings than Nano-X Imaging. Neuronetics is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	1.55	-$39M	-$0.44	N/A
Nano-X Imaging	$15.63M	3.64	-$75.02M	-$2.14	N/A

Neuronetics has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

Neuronetics has a net margin of -19.62% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-19.62%	-125.11%	-22.15%
Nano-X Imaging	-926.05%	-116.93%	-100.67%

In the previous week, Nano-X Imaging had 4 more articles in the media than Neuronetics. MarketBeat recorded 15 mentions for Nano-X Imaging and 11 mentions for Neuronetics. Neuronetics' average media sentiment score of 0.66 beat Nano-X Imaging's score of 0.18 indicating that Neuronetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	2 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nano-X Imaging	2 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Neuronetics currently has a consensus target price of $4.67, suggesting a potential upside of 54.02%. Nano-X Imaging has a consensus target price of $4.33, suggesting a potential upside of 498.69%. Given Nano-X Imaging's higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Neuronetics beats Nano-X Imaging on 10 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Pro-Dex?

Nano-X Imaging (NASDAQ:NNOX) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Pro-Dex has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$15.63M	3.64	-$75.02M	-$2.14	N/A
Pro-Dex	$77.55M	2.59	$13.66M	$4.13	15.21

Nano-X Imaging currently has a consensus price target of $4.33, indicating a potential upside of 498.69%. Pro-Dex has a consensus price target of $74.00, indicating a potential upside of 17.82%. Given Nano-X Imaging's higher possible upside, research analysts clearly believe Nano-X Imaging is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Pro-Dex has a net margin of 17.62% compared to Nano-X Imaging's net margin of -926.05%. Pro-Dex's return on equity of 25.13% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Pro-Dex	17.62%	25.13%	16.02%

In the previous week, Nano-X Imaging had 7 more articles in the media than Pro-Dex. MarketBeat recorded 15 mentions for Nano-X Imaging and 8 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.60 beat Nano-X Imaging's score of 0.18 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	2 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pro-Dex	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nano-X Imaging has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, indicating that its share price is 94% less volatile than the broader market.

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by company insiders. Comparatively, 45.9% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pro-Dex beats Nano-X Imaging on 10 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to Conexeu Sciences?

Nano-X Imaging (NASDAQ:NNOX) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Nano-X Imaging presently has a consensus target price of $4.33, indicating a potential upside of 498.69%. Conexeu Sciences has a consensus target price of $20.00, indicating a potential upside of 348.43%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts plainly believe Nano-X Imaging is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

21.5% of Nano-X Imaging shares are owned by institutional investors. 7.7% of Nano-X Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Conexeu Sciences has lower revenue, but higher earnings than Nano-X Imaging. Conexeu Sciences is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$15.63M	3.64	-$75.02M	-$2.14	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.11	N/A

Conexeu Sciences has a net margin of 0.00% compared to Nano-X Imaging's net margin of -926.05%. Conexeu Sciences' return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Conexeu Sciences	N/A	N/A	N/A

In the previous week, Nano-X Imaging had 13 more articles in the media than Conexeu Sciences. MarketBeat recorded 15 mentions for Nano-X Imaging and 2 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.37 beat Nano-X Imaging's score of 0.18 indicating that Conexeu Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Nano-X Imaging	Neutral
Conexeu Sciences	Neutral

Summary

Nano-X Imaging beats Conexeu Sciences on 9 of the 15 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NNOX vs. The Competition

Export

Metric	Nano-X Imaging	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$57.38M	$5.38B	$7.14B	$12.72B
Dividend Yield	N/A	1.79%	2.56%	11.15%
P/E Ratio	-0.34	25.09	275.24	25.29
Price / Sales	3.64	82.90	656.02	98.94
Price / Cash	N/A	32.53	77.04	51.44
Price / Book	0.36	5.97	10.33	6.20
Net Income	-$75.02M	$150.75M	$3.50B	$358.50M
7 Day Performance	-12.77%	-2.83%	-3.32%	-2.35%
1 Month Performance	-29.04%	-3.09%	-0.41%	-2.77%
1 Year Performance	-81.44%	9.34%	19.21%	7.63%

Nano-X Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NNOX Nano-X Imaging	3.9586 of 5 stars	$0.72 -0.9%	$4.33 +498.7%	-81.8%	$57.38M	$15.63M	N/A	190	News Coverage Earnings Report Gap Up
PROF Profound Medical	2.6719 of 5 stars	$6.80 -0.7%	$11.50 +69.1%	+50.8%	$248.94M	$16.10M	N/A	150	Analyst Downgrade Gap Up
ELMD Electromed	3.251 of 5 stars	$27.97 -5.5%	$43.75 +56.4%	+8.7%	$234.00M	$73.78M	37.29	160	High Trading Volume
STIM Neuronetics	3.9002 of 5 stars	$2.84 -3.4%	$4.50 +58.5%	-12.4%	$224.02M	$149.16M	N/A	180	News Coverage Positive News Analyst Forecast
PDEX Pro-Dex	3.2682 of 5 stars	$62.10 -0.7%	$70.00 +12.7%	+78.5%	$199.72M	$66.59M	17.15	140	News Coverage Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NNOX) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nano-X Imaging (NNOX) Competitors

NNOX vs. PROF, ELMD, STIM, PDEX, and CNXU

How does Nano-X Imaging compare to Profound Medical?

Summary

How does Nano-X Imaging compare to Electromed?

Summary

How does Nano-X Imaging compare to Neuronetics?

Summary

How does Nano-X Imaging compare to Pro-Dex?

Summary

How does Nano-X Imaging compare to Conexeu Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nano-X Imaging (NNOX) Competitors

NNOX vs. PROF, ELMD, STIM, PDEX, and CNXU

How does Nano-X Imaging compare to Profound Medical?

Do insiders & institutionals believe in PROF or NNOX?

Does the media favor PROF or NNOX?

Which has preferable earnings and valuation, PROF or NNOX?

Do analysts recommend PROF or NNOX?

Which has more volatility & risk, PROF or NNOX?

Is PROF or NNOX more profitable?

Summary

How does Nano-X Imaging compare to Electromed?

Do analysts prefer ELMD or NNOX?

Which has more risk and volatility, ELMD or NNOX?

Is ELMD or NNOX more profitable?

Does the media favor ELMD or NNOX?

Which has stronger valuation and earnings, ELMD or NNOX?

Do insiders and institutionals believe in ELMD or NNOX?

Summary

How does Nano-X Imaging compare to Neuronetics?

Do institutionals & insiders believe in STIM or NNOX?

Which has better earnings and valuation, STIM or NNOX?

Which has more risk and volatility, STIM or NNOX?

Is STIM or NNOX more profitable?

Does the media favor STIM or NNOX?

Do analysts rate STIM or NNOX?

Summary

How does Nano-X Imaging compare to Pro-Dex?

Which has preferable valuation & earnings, NNOX or PDEX?

Do analysts prefer NNOX or PDEX?

Is NNOX or PDEX more profitable?

Does the media refer more to NNOX or PDEX?

Which has more volatility & risk, NNOX or PDEX?

Do institutionals and insiders believe in NNOX or PDEX?

Summary

How does Nano-X Imaging compare to Conexeu Sciences?

Do analysts prefer NNOX or CNXU?

Do insiders and institutionals believe in NNOX or CNXU?

Which has stronger earnings and valuation, NNOX or CNXU?

Is NNOX or CNXU more profitable?

Does the media refer more to NNOX or CNXU?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools